Development of antitumor biguanides targeting energy metabolism and stress responses in the tumor microenvironment
Abstract To develop antitumor drugs capable of targeting energy metabolism in the tumor microenvironment, we produced a series of potent new biguanide derivatives via structural modification of the arylbiguanide scaffold. We then conducted biological screening using hypoxia inducible factor (HIF)-1-...
Guardado en:
Autores principales: | Takayuki Sakai, Yoshiyuki Matsuo, Kensuke Okuda, Kiichi Hirota, Mieko Tsuji, Tasuku Hirayama, Hideko Nagasawa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6759b22745514a5c8c9a25f41acea83c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth
por: Audrey Hébert, et al.
Publicado: (2021) -
Mild Biamidine-Transfer Conditions for the Synthesis of Aliphatic Biguanides
por: Rostyslav Bardovskyi, et al.
Publicado: (2021) -
Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment
por: Huang Jian-Ming, et al.
Publicado: (2021) -
Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation of Interferon Pathway in the Tumor Microenvironment
por: Glauco Akelinghton Freire Vitiello, et al.
Publicado: (2021) -
The Metabolic Control of Myeloid Cells in the Tumor Microenvironment
por: Eloise Ramel, et al.
Publicado: (2021)